You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti Xa

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vasopressors on Anti-Xa Activity in Critically Ill Patients

Recruiting
  • Critical Illness
  • Thrombosis
  • Serum anti-Xa activity
  • Gdańsk, Poland
    Medical University of Gdańsk - Departament of Anesthesiology and
Sep 20, 2023

Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19

Completed
  • Critical Illness
  • +2 more
  • blood sampling
  • Arnhem, Netherlands
    Monique de Maat
Jun 28, 2023

LR-ACT and Anti Xa Activity During Endovascular Surgery

Not yet recruiting
  • Aortic Diseases
  • +2 more
  • Anti Xa activity measurement.
  • Bron, France
    Service de chirurgie vasculaire (U50) Hôpital Louis Pradel - HCL
Sep 21, 2022

Nephrotic Syndrome Trial in Warsaw (Enoxaparin)

Terminated
  • Nephrotic Syndrome
  • Warsaw, Masovian District, Poland
    Military Institute of Medicine
Jan 26, 2023

Venous Thromboembolism Trial (Peak value anti-Xa, Trough value anti-Xa, Control Group)

Not yet recruiting
  • Venous Thromboembolism
  • Peak value anti-Xa
  • +2 more
  • (no location specified)
May 15, 2022

Anticoagulants and Bleeding Disorders, Surgery, Regional Anesthesia Morbidity Trial in Winston-Salem (Enoxaparin)

Terminated
  • Anticoagulants and Bleeding Disorders
  • +2 more
  • Winston-Salem, North Carolina
    Wake Forest University Baptist Medical Center
Dec 4, 2022

Dose Regimen of Intravenous Unfractionated Heparin and Low

Active, not recruiting
  • COVID-19
  • +3 more
  • Gent, Belgium
    Ghent University Hospital
Oct 24, 2022

Anti-Xa Activity Trial in Vancouver (apixaban)

Terminated
Has Results
  • Anti-Xa Activity
  • Vancouver, British Columbia, Canada
    Vancouver General Hospital
Jul 28, 2021

Dose Adjustment of Enoxaparin in ICU Patients Trial in Kfar Saba (Dose adjustment of Enoxaparin in patients with sub-therapuetic

Completed
  • Dose Adjustment of Enoxaparin in ICU Patients
  • Dose adjustment of Enoxaparin in patients with sub-therapuetic (prophylactic) levels of factor 10a
  • Kfar Saba, Israel
    Meir Medical Center
Jan 23, 2022

Traumatic Injury, Venous Thromboembolism Trial in Cincinnati (Enoxaparin 40 mg q12h, Enoxaparin 30 mg q8h)

Completed
Has Results
  • Traumatic Injury
  • Venous Thromboembolism
  • Enoxaparin 40 mg q12h
  • Enoxaparin 30 mg q8h
  • Cincinnati, Ohio
    University of Cincinnati Medical Center
Oct 22, 2021

Dextran Sulphate on Anti-Xa Activities Measured

Completed
  • Unfractionated Heparin Treatment
  • measurement of anti-Xa activities
  • Bordeaux, France
  • +7 more
Feb 8, 2021

Is Anti-Factor Xa Associated With Outcome in Critical COVID-19

Completed
  • Covid19
  • +2 more
  • The effect of LMWH
  • Monitoring frequency of aFXa-levels
  • Stockholm, Sweden
    Södersjukhuset
Feb 24, 2022

Precision Medicine Platform for Novel Oral Anticoagulants

Recruiting
  • Anticoagulant Adverse Reaction
  • Pharmacogenomics
  • Kaohsiung, Taiwan
    Kaohsiung Medical University Hospital
Aug 30, 2021

Deep Vein Thrombosis, Pulmonary Embolism, Venous Thromboembolism Trial in Salt Lake City (Standard heparin dose, Real time

Unknown status
  • Deep Vein Thrombosis
  • +2 more
  • Standard heparin dose
  • Real time heparin dose adjustment
  • Salt Lake City, Utah
    University of Utah
Nov 11, 2020

Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving

Not yet recruiting
  • Assessment of Activity of Anti-Xa Factor in Patients Treated With Continuous Veno-venous Hemodiafiltration Receiving Anticoagulant Prophylaxis
  • Assessment the activity of anti-Xa factor.
  • Gdańsk, Pomorskie, Poland
    Medical University of Gdansk - Departament of Anesthesiology and
Dec 15, 2020

Venous Thromboembolism, Pulmonary Embolism, Thromboprophylaxis Trial in Tampere (Enoxaparin)

Recruiting
  • Venous Thromboembolism
  • +2 more
  • Tampere, Pirkanmaa, Finland
    Tampere University Hospital
Feb 25, 2021

Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and

Unknown status
  • Anticoagulation
  • +2 more
  • Estimated anticoagulant level (conversion factor x anti-Xa activity)
  • (no location specified)
Nov 30, 2020

Heparin Requirements in Patients Undergoing Atrial Fibrillation

Completed
  • Atrial Fibrillation
  • Monitoring Anti Factor Xa level
  • Brighton, Massachusetts
    St Elizabeth Medical Center
Jul 15, 2021

Acute Coronary Syndrome Trial in Monastir (LOVENOX, ENOXAMED)

Completed
  • Acute Coronary Syndrome
  • Monastir, Tunisia
    Emergency Department of University Hospital of Monastir
Jul 20, 2020

Specific PoC Testing of Coagulation in Patients Treated With

Recruiting
  • Anticoagulation With NOAC
  • anti-Xa activity point-of-care testing (aXa-POCT)
  • ecarin clotting time point-of-care testing (ECT-POCT)
  • Tuebingen, Germany
    University Hospital Tuebingen
Dec 14, 2020

Symptomatic Aortic Stenosis, Eligible for Transcatheter Aortic Valve Replacement Trial in Worldwide (Apixaban, Standard of care)

Completed
  • Symptomatic Aortic Stenosis
  • Eligible for Transcatheter Aortic Valve Replacement
  • Paris, France
  • +3 more
Feb 24, 2021

Unfractionated Heparin in COVID-19 and Non-COVID-19 Patients

Recruiting
  • Heparin Overdose of Undetermined Intent
  • COVID-19
  • Unfractionated heparin
  • Leiden, Zuid-holland, Netherlands
    Leiden University Medical Centre
Aug 19, 2022

Pediatric Kidney Transplant Recipients Trial in Paris (Bayesian based dose adjustment of enoxaparin, Usual dose adjustment of

Not yet recruiting
  • Pediatric Kidney Transplant Recipients
  • Bayesian based dose adjustment of enoxaparin
  • Usual dose adjustment of enoxaparin
  • Paris, Ile-de-France, France
    Hôpital Necker - Enfants malades
Jan 23, 2023

Anticoagulation in Patients on ECMO for Severe Lung Failure

Completed
  • ARDS
  • COVID-19
  • Ostrava, Moravian-Silesian Region, Czechia
    University Hospital Ostrava
Sep 18, 2023

'CTR' Ratio With Standard Haemostasis Parameters in Follow-up of

Recruiting
  • Venous Thromboembolic Disease
    • Saint-Mandé, France
      HIA Bégin
    Aug 7, 2023